In intravenous drug abusers, infective endocarditis usually involves right-sided valves, with Staphylococcus aureus being the most common etiologic agent. We present a patient who is an intravenous drug abuser with leftsided (aortic valve) endocarditis caused by Enterococcus faecalis who subsequently developed an anterior mitral valve aneurysm, which is an exceedingly rare complication. A systematic literature search was conducted which identified only five reported cases in the literature of mitral valve aneurysmal rupture in the setting of E. faecalis endocarditis. Real-time 3D-transesophageal echocardiography was critical in making an accurate diagnosis leading to timely intervention.
Summary
In intravenous drug abusers, infective endocarditis usually involves right-sided valves, with Staphylococcus aureus being the most common etiologic agent. We present a patient who is an intravenous drug abuser with leftsided (aortic valve) endocarditis caused by Enterococcus faecalis who subsequently developed an anterior mitral valve aneurysm, which is an exceedingly rare complication. A systematic literature search was conducted which identified only five reported cases in the literature of mitral valve aneurysmal rupture in the setting of E. faecalis endocarditis. Real-time 3D-transesophageal echocardiography was critical in making an accurate diagnosis leading to timely intervention.
Background
Mitral valve aneurysm (MVA) is an uncommon condition that can occur as a complication of infective endocarditis of aortic valve or the mitral valve. Rupture of the aneurysm is the most feared complication, which can result in severe mitral regurgitation (MR) causing rapid hemodynamic deterioration especially in heart failure patients (1, 2, 3) . A timely diagnosis using Real-time 3D-transesophageal echocardiography (RT-3DTEE) and appropriate treatment such as surgical repair or replacement of the valve can prevent this catastrophic complication (2, 3) . We present a case of anterior MVA after aortic valve endocarditis and emphasize the role of RT-3DTEE in the early diagnosis and management of this condition.
Case presentation
A 41-year-old Caucasian male with history of intravenous drug use, chronic obstructive pulmonary disease and colorectal abscesses presented with a 3-week history of worsening shortness of breath. At the time of presentation, the patient endorsed extreme fatigue, night sweats, orthopnea and dyspnea. The patient denied chest pain, cough, nausea, or vomiting. Cardiac examination revealed a diastolic murmur along the left sternal border. Initial workup included computed tomographic angiogram (CTA) of the chest, which showed no evidence of pulmonary emboli. The 2D-transthoracic echocardiogram (TTE) demonstrated a 2.1 cm aortic valve vegetation as well as an abnormal ring-like structure on the mitral valve (Fig. 1A Learning objectives:
• Early recognition of a mitral valve aneurysm (MVA) is important because it may rupture and produce catastrophic mitral regurgitation (MR) in an already seriously ill patient requiring emergency surgery, or it may be overlooked at the time of aortic valve replacement (AVR).
• Real-time 3D-transesophageal echocardiography (RT-3DTEE) is much more advanced and accurate than transthoracic echocardiography for the diagnosis and management of MVA. infective endocarditis (Fig. 1C) . The view from the left ventricular side revealed a perforation in the A2 scallop (Fig. 1D ). Blood cultures returned positive for Enterococcus faecalis bacteremia. The bacteremia was attributed to the use of rectal methamphetamine suppositories complicated by rectal abscesses. Based on RT-3DTEE findings of severe symptomatic aortic regurgitation and anterior mitral valve aneurysm the patient underwent urgent surgery. Intraoperatively, the patient was found to have a large 2 × 2 cm perforation through A2 of the mitral valve ( Fig. 2A ). There was a large ballooning piece of tissue seen over the perforation in the A2 scallop of the anterior leaflet, corresponding to the preoperative 3DTEE findings. The excess aneurysmal tissue and leaflet were resected. The aortic valve had several vegetations with ragged edges (Fig. 2B) , and there was malcoaptation of the leaflets as demonstrated on RT-3DTEE. The patient underwent successful aortic and mitral valve replacements. Cultures of the valves also grew E. faecalis. The patient was subsequently discharged on ampicillin and streptomycin for 6 weeks and infectious disease follow-up.
Discussion
Our patient developed aortic valve enterococcal endocarditis, most likely due to use of rectal methamphetamine suppositories. The patient subsequently developed colorectal abscesses, requiring a colostomy. Enterococcus is the third leading etiological agent for bacterial endocarditis after viridans streptococci and staphylococci, and accounts for approximately 8% of all cases of bacterial endocarditis (4) . The patients at the highest risk for developing enterococcal endocarditis include elderly men subjected to multiple genitourinary procedures, young women with postpartum and genitourinary infections, and intravenous drug users (5). These patients commonly present with fever, night sweats, weight loss, malaise, heart murmurs and symptoms due to cardiac failure. MVA is a rare complication. To the best of our knowledge, only 10 cases of MVA in enterococcal endocarditis have been reported in the literature (Tables 1,  2 and 3) . A further systematic literature search was conducted using Medline (via PubMed), Embase, Scopus and Google Scholar, which identified only five reported cases from E. faecalis endocarditis ( Table 1) . The typical occurrence is in the presence of aortic valve endocarditis, rheumatic disease and other disorders causing connective tissue degeneration (3, 6, 7) . Rarely, MVA has been reported in noninfectious etiologies like connective tissue disorders such as Marfan syndrome, Ehlers-Danlos syndrome, pseudoxanthoma elasticum and some cases of mitral valve prolapse (8, 9, 10, 11) .
MVA is a rare condition with reported incidence of 0.29% on 4500 TEE examinations (12) . On TTE it looks like a saccular bulge of the mitral leaflet protruding toward the left atrium with systolic expansion and diastolic collapse. The diastolic expansion may occur with AR or after rupture of the MVA (13). Anterior MVA is more commonly observed than the posterior MVA (13, 14) . The development of MVA is likely due to the infected aortic regurgitant jets striking the ventricular surface of the anterior mitral leaflet (Fig. 1E) causing physical trauma and possible occult mitral leaflet infection. This is manifested by valvulitis and the formation of sac-like outpouchings due to formation of scar tissue and granulation tissue on microscopic examination. The extension of infection to the mitral-aortic intervalvular fibrosa results in abscess or aneurysm formation (1, 2, 10) . However, the posterior MVA occurs as a result of weakness of the mitral valve secondary to myxomatous degeneration and latent infective endocarditis (15) . The MVA is of variable shape and size and can easily be confused with other mitral valve masses. According to Gular and coworkers, these aneurysms range in size from 5 to 12 mm in diameter during ventricular systole. The differential diagnosis of MVA includes mitral valve prolapse, myxomatous degeneration of the mitral valve, flail mitral leaflet, papillary fibroelastoma, myxoma involving the mitral valve, and mitral valve blood cysts without endothelization and mitral valve diverticulum (13) . The potential complications of MVA include endocarditis, thromboembolization and rupture of the aneurysm or perforation of the valve leaflet leading to acute, severe mitral regurgitation and pulmonary edema www.echorespract.com K12 (10, 16) . Vilacosta and coworkers studied the natural course of these aneurysms with serial echocardiographic follow-up and concluded that they undergo progressive expansion and subsequent rupture or perforation (12) . The vegetation or thrombus formation may occur within the aneurysm leading to thromboembolism and spread of infection (11) . Transthoracic echocardiography can demonstrate MVA as a localized saccular bulge of the mitral valve leaflet toward the left atrium, which persists throughout the cardiac cycle. However, it can be challenging to localize the exact site and size of aneurysmal rupture because of the inherent limitations of 2D-transthoracic echocardiography (16) . Therefore, the presence of mitral aneurysm may be missed in important clinical situations such as critically ill patients with aortic valve endocarditis or during the preoperative cardiac assessment of mitral valve prior to aortic valve replacement in setting of endocarditis (3, 6, 7, 17) . Hence, RT-3DTEE, which is superior to TTE for the definitive diagnosis and precise determination of MVA, should be employed to guide management decisions in such circumstances. This case clearly demonstrates that the use of RT-3DTEE was critical in making an accurate diagnosis and planning the appropriate surgical approach with a successful outcome in our patient with this rare presentation (16) .
A conservative approach for small, uncomplicated aneurysms is a reasonable option with close follow-up; but surgical options are utilized in cases with large unruptured aneurysms or in the setting of perforation or rupture of the aneurysm with or without significant MR (18) . Mitral valve repair in the setting of infective endocarditis has been shown to have good clinical in-hospital and long-term results as compared to MV replacement (19, 20) . The effective utilization of 3DTEE is invaluable for the success of surgical repair in these settings (20) . The accurate determination of the size of the perforation and preoperative 3D pictures of the MVA utilizing TEE is tremendously helpful for operative planning. The RT-3DTEE images and operative findings coincided in 92% of cases in a study conducted by Kanzaki and coworkers. The diagnostic capability of 3D-TEE depends on the leaflet segment or scallop with 67-100% and 100% sensitivity for detecting lesions at anterior and posterior leaflet, respectively; and specificities of 78-100% and 100% at anterior and posterior leaflet, respectively (21) .
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